Edition:
United States

MEDNAX Inc (MD.N)

MD.N on New York Stock Exchange

51.03USD
20 Apr 2018
Change (% chg)

$-0.97 (-1.87%)
Prev Close
$52.00
Open
$51.89
Day's High
$52.02
Day's Low
$50.96
Volume
117,983
Avg. Vol
256,648
52-wk High
$62.75
52-wk Low
$40.56

Select another date:

Fri, Mar 23 2018

BRIEF-Mednax Says CEO Roger Medel's Total Compensation For 2017 Was $7.4 Mln Versus $7.8 Mln In 2016

* MEDNAX INC SAYS CEO ROGER J. MEDEL'S TOTAL COMPENSATION FOR 2017 WAS $7.4 MILLION VERSUS $7.8 MILLION IN 2016 - SEC FILING‍​ Source text: [https://bit.ly/2pzvmAc] Further company coverage:

BRIEF-Mednax Reports Q4 Adjusted Earnings Per Share Of $0.87

* Q4 EARNINGS PER SHARE VIEW $0.83, REVENUE VIEW $885.1 MILLION -- THOMSON REUTERS I/B/E/S

Deals of the day-Mergers and acquisitions

Dec 1 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

Mednax fielding takeover interest from buyout firms: sources

Mednax Inc, a U.S. healthcare network operator targeted by activist hedge fund Elliott Management Corp, is fielding acquisition interest from several private equity firms, according to people familiar with the matter.

UPDATE 1-Mednax fielding takeover interest from buyout firms -sources

Dec 1 Mednax Inc, a U.S. healthcare network operator targeted by activist hedge fund Elliott Management Corp, is fielding acquisition interest from several private equity firms, according to people familiar with the matter.

BRIEF-Elliott, Elliott International & EICA collectively combines economic exposure in MEDNAX

* Elliott says Elliott, Elliott International & EICA collectively have combined economic exposure in MEDNAX of about 7.0% of stock as of Nov 6

BRIEF-Mednax reports Q3 earnings per share of $0.71

* Mednax reports third quarter GAAP EPS of $0.71; adjusted EPS of $0.87

Select another date: